Journals / Türk Biyokimya Dergisi / 2013 / Cilt: 38 - Sayı: 4

Myelin basic protein profile of central nervous system in experimentally induced demyelination and remyelination

Deneysel demiyelinasyon ve remiyelinasyonda merkezi sinir sisteminin miyelin temel protein profili

Pages
451–456
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study will contribute to the understanding of the mechanisms of demyelination and remyelination as well as will serve a base for the future studies investigating diseases characterized by demyelination in human and animals

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the present study was to assess myelin basic protein (MBP) profiles of central nervous system in experimentally induced demyelination and remyelination.
📊
Key Findings & Data:Materials and Methods: Sixty 8-10 weeks old male C57Bl/6 mice were used for this study.
💡
Conclusion & Impact:This study will contribute to the understanding of the mechanisms of demyelination and remyelination as well as will serve a base for the future studies investigating diseases characterized by demyelination in human and animals
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the present study was to assess myelin basic protein (MBP) profiles of central nervous system in experimentally induced demyelination and remyelination. Materials and Methods: Sixty 8-10 weeks old male C57Bl/6 mice were used for this study. Twenty mice were selected as control and 40 mice as experimental group. Experimental group was fed ad libitum with a 0.3 % cuprizone diet for 6 weeks. At the end of 6 weeks, 20 mice from the experimental group and 10 mice from the control group were euthanasied and the remaining of the experimental group was fed cuprizone-free diet for more 4 weeks and then 10 mice in the control group and 20 mice in the experimental group were sacrificed. Corpus callosum sections were removed and protein extraction was performed in all samples. The MBP profiles were evaluated by sodium dodecyl sulphate - polyacrylamide gel electrophoresis and Western-blot analysis. Results and Conclusion: Decreased intensity of the MBP isoforms below the 26.6 kDa was observed in demyelinated group as compared with controls. In the remylinated group, intensity of MBP approached to values of control group. This study will contribute to the understanding of the mechanisms of demyelination and remyelination as well as will serve a base for the future studies investigating diseases characterized by demyelination in human and animals

Özet

Amaç: Bu çalışmanın amacı, deneysel demiyelinasyon ve remiyelinasyonda merkezi sinir sisteminin miyelin temel protein (MBP) profilini değerlendirmektir.Gereç ve Yöntemler: Bu çalışmada 60 adet, 8-10 haftalık erkek C57BL/6 fare kullanıldı. Farelerden yirmi adeti kontrol grubu, 40 adeti deneme grubu olarak ayrıldı. Deneme grubundaki fareler 6 hafta boyunca % 0.3 kuprizon içeren diyet ile beslendi. Bu süre sonunda, deneme grubundan 20 fare ile kontrol grubundan 10 farenin ötanazileri yapıldı. Deneme grubundaki diğer 20 fare ile kontrol grubundaki 10 fare, remiyelinasyon oluşturmak amacıya, 4 hafta boyunca kuprizon içermeyen diyet ile beslendi ve sakrifiye edildi. Farelerin korpus kallosumları çıkartıldı ve tüm örneklerde protein ekstraksiyonu yapıldı. MBP profilleri SDSPAGE ve Western-blot analizi ile değerlendirildi.Bulgular ve Tartışma: Demiyelinasyon grubunda 26.6 kDa altındaki MBP izoformlarının yoğunluğunun kontrol grubuna göre azaldığı gözlendi. Remiyelinasyon grubunda MBP yoğunluğunun kontrol grubundaki düzeye yaklaştığı belirlendi. Bu çalışma, demiyelinasyon ve remiyelinasyon mekanizmalarının anlaşılmasına katkıda bulunmasının yanı sıra, insan ve hayvanlarda demiyelinasyon ile karakterize hastalıklarla ilgili çalışmalar için temel teşkil edecektir

🔖

Cite This Article

KARAYİĞİT, M. Ö., YARIM, M., YARIM, G. F., ÇİFTCİ, G. (2022). Myelin basic protein profile of central nervous system in experimentally induced demyelination and remyelination. Türk Biyokimya Dergisi, Cilt: 38 - Sayı: 4, 451–456. https://ajindex.com/articles/621234

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Carnegie PR, Dunkley PR. Basic protein of central and peripheral nervous system myelin. In (Eds. Agranoff BW, Aprison MH) Advances in Neurochemistry 1975; pp. 95-135, Plenum Press, New York
  2. Cohen SR, Guarnieri M. Immunochemical measurement of myelin basic protein in developing rat brain: an index of myelin synthesis. Dev Biol 1976; 49:294-299
  3. Chernoff GF. Shiverer: An autosomal recessive mutant mouse with myelin deficiency. J Hered 1981; 72:128
  4. Bodhireddy SR, Lyman WD, Rashbaum WK, Weidenheim KM. Immunohistochemical detection of myelin basic protein is a sensitive marker of myelination in second trimester human fetal spinal cord. J Neuropathol Exp Neurol 1994; 53:144-149
  5. Barbarese E, Braun PE, Carson JH. Identification of prelarge and presmall basic proteins in mouse myelin and their structural relationship to large and small basic proteins. PNAS 1977; 74:3360-3364
  6. De Ferra F, Engh H, Hudson L, Kamholz J, Puckett C, et al. Alternative splicing accounts for the four forms of myelin basic protein. Cell 1985; 43:721-727
  7. Akiyama K, Ichinose S, Omori A, Sakurai Y, Asou H. Study of expression of myelin basic proteins (mbps) in developing rat brain using a novel antibody reacting with four major isoforms of MBP. J Neurosci Res 2002; 68:19-28
  8. Allinquant B, Staugaitis SM, D’urso D, Colman DR. The ectopic expression of myelin basic protein isoforms in shiverer oligodendrocytes: implications for myelinogenesis. J Cell Biol 1991; 113:393-403
  9. Jacque C, Delassalle A, Rancurel G, Raoul M, Lesourd B, et al. Myelin basic protein in csf and blood. Relationship between its presence and the occurrence of a destructive process in the brains of encephalitic patients. Arch Neurol 1982; 39:557-560
  10. Lamers KJ, Van Engelen BG, Gabreels FJ, Hommes OR, Borm GF, et al. Cerebrospinal neuron-specific enolase, s-100 and myelin basic protein in neurological disorders. Acta Neurol Scand 1995; 92:247-251
  11. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. NEJM 2003; 349:139- 145
  12. Allen IV. Demyelinating diseases. In (Eds. Adams JH, Greenfield JG, Corsellis JAN, Duchen LW) Greenfield’s Neuropathology 1984; pp. 338-384, Edward Arnold, London
  13. Vinken PJ, Bruyn GW, Klawans HL, Koetsier JC (Eds). Handbook of Clinical Neurology. 1985; pp. 213-287, North Holland Publishing Company, Amsterdam
  14. Bunge MB, Bunge RP,